English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51899856    在线人数 :  1130
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"liu c h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 691-740 / 1570 (共32页)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-04-22T06:56:48Z Biliary hamartomas with delayed 99mTc-diisopropyl iminodiacetic acid clearance Liu C.-H.; Yen R.-F.; Liu K.-L.; Jeng Y.-M.; Pan M.-H.; PEI-MING YANG
臺大學術典藏 2021-04-22T06:56:47Z Gastroduodenal corrosive injury after oral zinc oxide Liu C.-H.; Lee C.-T.; Tsai F.-C.; Hsu S.-J.; PEI-MING YANG
臺大學術典藏 2021-04-22T06:56:47Z Splenic vein thrombosis and Klebsiella pneumoniae septicemia after endoscopic gastric variceal obturation therapy with N-butyl-2-cyanoacrylate Liu C.-H.; Tsai F.-C.; Liang P.-C.; Lee C.-Z.; PEI-MING YANG
臺大學術典藏 2021-04-22T06:56:46Z Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases Liu C.-H.; Lin J.-W.; Tsai F.-C.; PEI-MING YANG; Lai M.-Y.; Chen J.-H.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-04-22T06:56:46Z Gastroduodenal corrosive injury after oral zinc oxide [4] Liu C.-H.; Lee C.-T.; Tsai F.-C.; Hsu S.-J.; PEI-MING YANG
臺大學術典藏 2021-04-22T06:56:45Z Successful colonoscopic drainage of appendiceal pus in acute appendicitis Liu C.-H.; Tsai F.-C.; Hsu S.-J.; PEI-MING YANG
臺大學術典藏 2021-04-22T06:56:44Z Enterolith ileus in a patient with jejunal diverticulosis: Sonographic findings Liu C.-H.; Huang K.-W.; Mo Y.-H.; PEI-MING YANG
臺大學術典藏 2021-04-22T06:56:43Z Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis Liu C.-H.; Hsu S.-J.; Liang C.-C.; Tsai F.-C.; Lin J.-W.; Liu C.-J.; PEI-MING YANG; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-04-16T07:31:05Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Chiu H.-M.;Jen G.H.-H.;Wang Y.-W.;Fann J.C.-Y.;Hsu C.-Y.;Jeng Y.-C.;Yen A.M.-F.;Chiu S.Y.-H.;Chen S.L.-S.;Hsu W.-F.;Lee Y.-C.;Wu M.-S.;Wu C.-Y.;Jou Y.-Y.;Hsiu-Hsi Chen; Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; HSIU-HSI CHEN; Chen P.-J.; Kao J.-H.
臺大學術典藏 2021-04-16T07:31:05Z Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands Tseng T.-C.;Liu C.-J.;Yang W.-T.;Hsu C.-Y.;Hong C.-M.;Su T.-H.;Tsai C.-H.;Chen C.-L.;Yang H.-C.;Liu C.-H.;Hsiu-Hsi Chen;Chen P.-J.;Kao J.-H.; Chiang T.-H.; Maeda M.; Yamada H.; Chan C.-C.; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; HSIU-HSI CHEN; Ushijima T.; Graham D.Y.; Lee Y.-C.
臺大學術典藏 2021-03-15T07:59:52Z Seroepidemiology of Human T-Cell Lymphotropic Virus Type I Infection in Taiwan Wang C.-H.;Chen C.-J.;Chung-Yi Hu;You S.-L.;Chu C.-T.;Chou M.-J.;Essex M.;Blattner W.A.;Liu C.-H.;Yang C.-S.; Wang C.-H.; Chen C.-J.; CHUNG-YI HU; You S.-L.; Chu C.-T.; Chou M.-J.; Essex M.; Blattner W.A.; Liu C.-H.; Yang C.-S.
臺大學術典藏 2021-03-15T07:59:52Z Infection of human T-cell leukemia virus type I and development of human T-cell leukemia/lymphoma in patients with hematologic neoplasms: A possible linkage to blood transfusion Chen Y.-C.;Wang C.-H.;Su I.-J.;Chung-Yi Hu;Chou M.-J.;Lee T.-H.;Lin D.-T.;Chung T.-Y.;Liu C.-H.;Yang C.-S.; Chen Y.-C.; Wang C.-H.; Su I.-J.; CHUNG-YI HU; Chou M.-J.; Lee T.-H.; Lin D.-T.; Chung T.-Y.; Liu C.-H.; Yang C.-S.
臺大學術典藏 2021-03-12T02:28:42Z Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load Wang J.-Y.;Liu C.-H.;Hu F.-C.;Chang H.-C.;Liu J.-L.;Chen J.-M.;Yu C.-J.;Li-Na Lee;Kao J.-H.;Yang P.-C.; Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; LI-NA LEE; Kao J.-H.; Yang P.-C.
臺大學術典藏 2021-03-09T06:46:21Z Hodgkin's disease and non?hodgkin's lymphoma containing reed?sternberg?like giant cells in Taiwan: A clinicopathologic analysis of 50 cases RUEY-LONG HONG; Su I.?J.; Chen Y.?C.; Hsieh H.?C.; Wang C.?H.; Liu C.?H.; Shen M.?C.
臺大學術典藏 2021-03-09T01:47:47Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B TUNG-HUNG SU; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:46Z HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; TUNG-HUNG SU; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:46Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:46Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:45Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:45Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:44Z Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; TUNG-HUNG SU; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:44Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:43Z Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:43Z Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:42Z Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:42Z Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C TUNG-HUNG SU; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:41Z Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:41Z Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:41Z Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy TUNG-HUNG SU; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:40Z Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin Chen M.-Y.; Liu C.-H.; Chen T.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:40Z Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:40Z Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications Wu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:39Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:38Z Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; TUNG-HUNG SU; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition TUNG-HUNG SU; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:37Z Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; TUNG-HUNG SU; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:36Z Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-03-09T01:47:35Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; TUNG-HUNG SU; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:33Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:25Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; Liu C.-J.; TUNG-HUNG SU; Fang Y.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:25Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:24Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:43:24Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients Liu C.-H.; Liu C.-J.; Hong C.-M.; TUNG-HUNG SU; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏 2021-03-09T01:43:24Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis TUNG-HUNG SU; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; Huang K.-W.; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H.

显示项目 691-740 / 1570 (共32页)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每页显示[10|25|50]项目